Deep Currents Investment Group LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Deep Currents Investment Group LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $15,625 - $20,194	205 New	205 $19,000
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $30,709 - $41,044	350 New	350 $34,000
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $1.67 Million - $2.27 Million	-23,400 Reduced 85.71%	3,900 $330,000
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $3.07 Million - $4.12 Million	-47,700 Reduced 63.6%	27,300 $2.31 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $2.95 Million - $3.45 Million	35,000 Added 87.5%	75,000 $6.66 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $3.21 Million - $4.24 Million	40,000 New	40,000 $3.41 Million

638

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Deep Currents Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Deep Currents Investment Group LLC with notifications on news.